Income Tax Expense (Benefit) of LB PHARMACEUTICALS INC from 30 Sep 2024 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
LB PHARMACEUTICALS INC quarterly Income Tax Expense (Benefit) in USD history and change rate from 30 Sep 2024 to 30 Sep 2025.
  • LB PHARMACEUTICALS INC Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was $0.
Source SEC data
View on sec.gov
Income Tax Expense (Benefit), Quarterly (USD)

LB PHARMACEUTICALS INC Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $0 $0 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $0 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.